biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Next two days….

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Jun 29, 2021 9:59am

151 Views

Post# 33465506

RE:RE:RE:Next two days….

I think its time to vote debra out if we don't get any news in the next 2-3 weeks.

Geez, how about waiting those 2-3 weeks before getting bent.

If you think a new CEO could do any better with no money in the bank, you're dreaming.

I'm not optimistic about the speed of the timeline, but the CEO isn't the problem.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment